Back
Madrigal Pharmaceuticals Vs. Enterprise Financial Services Industry Stock Comparison
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
236.12
Seasonality Move:
23.49%
Sell
50
EFSC
Enterprise Financial Services
Last Price:
51.23
Seasonality Move:
6.3%
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $241.80. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Enterprise Financial Services (EFSC)
is a Sell
Is Enterprise Financial Services a Buy, Sell or Hold?
- The current Enterprise Financial Services [EFSC] share price is $51.44. The Score for EFSC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EFSC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $241.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.
EFSC Stock Price Chart
What is Enterprise Financial Services's stock price today?
-
The Enterprise Financial Services share price today is $51.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.05 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 47346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.56 - 253.3) | Sell |
| Bollinger Bands (100): | (224.06 - 277.86) | Sell |
EFSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 56.69 | Buy |
| Chaikin Money Flow: | 83213 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.09 - 52.15) | Buy |
| Bollinger Bands (100): | (38.27 - 49.87) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 239.91 | Buy |
| 20-day SMA: | 246.89 | Sell |
| 50-day SMA: | 261.43 | Sell |
| 200-day SMA: | 242.07 | Sell |
| 8-day EMA: | 239.77 | Buy |
| 20-day EMA: | 245.3 | Sell |
| 50-day EMA: | 252.82 | Sell |
| 200-day EMA: | 240.02 | Buy |
EFSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.66 | Buy |
| 20-day SMA: | 51.18 | Buy |
| 50-day SMA: | 49.15 | Buy |
| 200-day SMA: | 42.55 | Buy |
| 8-day EMA: | 50.87 | Buy |
| 20-day EMA: | 50.75 | Buy |
| 50-day EMA: | 48.69 | Buy |
| 200-day EMA: | 43.72 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Enterprise Financial Services Earnings Growth & EFSC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.07 per share.
Madrigal Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enterprise Financial Services Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||